This ICR collects information from
manufacturers who are required to conduct postmarket surveillance
of a medical device that meets the criteria set forth in the
statute. The postmarket surveillance submission includes the
postmarket plan, information about the person designated to conduct
the surveillance, and organizational/administrative information.
The information collection also includes the submission of changes
to the plan, requests for a waiver of any requirement of the
regulation, requests for exemption from the requirement to conduct
postmarket surveillance, and submission of periodic reports as
specified in the postmarket surveillance plan. Additionally,
manufacturers and investigators must maintain records to ensure
that the postmarket surveillance is conducted in accordance with
the approved plan. The information collected and maintained enables
FDA to ensure that the postmarket surveillance will result in the
collection of useful data that can reveal unforeseen adverse events
or other information necessary to protect the public
health.
Our estimated burden for the
information collection reflects a decrease of 29,982 hours. We
attribute this adjustment to a decrease in the number of
submissions we received over the last few years.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.